Thrombocytopenia in adults: A practical approach to evaluation and management.

@article{Sekhon2006ThrombocytopeniaIA,
  title={Thrombocytopenia in adults: A practical approach to evaluation and management.},
  author={S. S. Sekhon and V. Roy},
  journal={Southern medical journal},
  year={2006},
  volume={99 5},
  pages={
          491-8; quiz 499-500, 533
        }
}
With the widespread use of automated cell counters, clinicians in any field of medicine may encounter thrombocytopenia. The symptomatology may vary greatly and the underlying cause may be either inconsequential (pseudothrombocytopenia) or life threatening. It is important to be aware of common conditions leading to thrombocytopenia and have a systematic approach to evaluation and management of these patients. In this review we highlight common etiologies seen in adult patients with… Expand
Evaluation of Thrombocytopenia in a Tertiary Care Centre
Thrombocytopenia is a common clinical problem with many etiological causes. This may result due to decreased platelet production, increased destruction of platelets and differentiation inExpand
Literature Survey : Approach to a patient with Thrombocytopenia 2
Background:Thrombocytopenia is the most common cause of abnormal bleeding. The causes of thrombocytopenia are diverse but they can be grouped according to the pathogenesis into immune and non-immuneExpand
Clinicopathological Study of Non – ImmuneThrombocytopenia
TLDR
The Analysis of Adult Patients Confirmed With Thrombocytopenia Using Clinical and Relevant Laboratory parameters to Assure At A Possible Aetiopathogenesis is focused on. Expand
Narrative Review on Different Clinical Aspects of Thrombocytopenia
TLDR
The major causes of thrombocytopenia are summarized, the main general symptoms are characterized and the diagnosis and treatment methods are summarized. Expand
Thrombocytopenia: an update
TLDR
This review article aims to summarize and address appropriate work‐up of the major and/or life‐threatening causes of thrombocytopenia and some of the better‐characterized congenital thromBocy topenias. Expand
[Acute profound thrombocytopenia associated with tirofiban: clinical approach to diagnosis and therapeutic management].
TLDR
A case of a patient with acute coronary syndrome scheduled for urgent percutaneous coronary intervention who developed acute profound thrombocytopenia during treatment with intravenous tirofiban and was treated with steroids, immunoglobulin and platelet transfusion. Expand
Thrombocytopenia in Adults: Review Article
TLDR
Both hereditary and acquired reasons help thrombocytopenia have wide spreaded, but acquired causes are more common with increasing age, according to geographical distribution and application centers. Expand
Idiopathic thrombocytopenic purpura: laboratory diagnosis and management
TLDR
Management of ITP is based on platelet count and severity of bleeding, and treatment is aimed at interfering with antibodies that damage the platelets, by inhibiting the functions of macrophage Fca receptors and decreasing the production of antiplatelet antibodies. Expand
Assessment of Patients With Thrombocytopenia Followed in Our Clinic
TLDR
When platelet counts at discharge and the number of these patients died were compared, no significant difference was found between giving platelets extracted from whole blood or by means of apheresis, and the etiology should be clarified in a patient who has established diagnosis of thrombocytopenia. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 43 REFERENCES
Therapy for Adults with Refractory Chronic Immune Thrombocytopenic Purpura
Adult chronic immune thrombocytopenic purpura (ITP) is an autoimmune disorder caused by one or more antiplatelet autoantibodies usually directed to the platelet glycoprotein IIb/IIIa complex, GPIb/IXExpand
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.
TLDR
This report begins with a brief summary of the panel’s recommendations, followed by a more detailed analysis of its methodology, the findings of the comprehensive literature review, and a full presentation of the recommendations. Expand
How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
TLDR
Although the increased survival rate is dramatic and recent advances in understanding the pathogenesis of these syndromes are remarkable, clinical decisions remain empirical, and the management decisions for patients with suspected TTP-HUS rely on individual experience and opinion, resulting in many different practice patterns. Expand
Incidence and Diagnosis of EDTA‐Dependent Pseudothrombocytopenia in a Consecutive Outpatient Population Referred for Isolated Thrombocytopenia
TLDR
Cases of EDTA‐dependent pseudothrombocytopenia (EDTA‐PTCP) were identified and the diagnosis was confirmed by the following findings: normal platelet numbers immediately after blood withdrawal; progressive fall of platelet counts and evident platelet clumping over time, only in EDTA-anticoagulated blood. Expand
Incidence of thrombocytopenia in an acute care hospital.
TLDR
The high association between thrombocytopenia and infection justifies a search for an infective process when one encounters an unexpected or unexplained reduction in the platelet count. Expand
Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients.
TLDR
Intervention of intravenous anti-D therapy in 261 non-splenectomized patients treated at the New York Hospital-Cornell Medical Center over the period from 1987 to 1994 is reported, finding that HIV+ patients show no adverse effects on hemoglobin decrease or HIV disease progression. Expand
The incidence of idiopathic thrombocytopenic purpura in adults increases with age.
TLDR
The incidence rate of idiopathic thrombocytopenic purpura in Danish adults diagnosed from April 1, 1973 to December 31, 1995 increased in the study period, and involved asymptomatic patients and old males who were both symptomatic or not symptomatic. Expand
Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
This chapter about the recognition, treatment, and prevention of heparin-induced thrombocytopenia (HIT) is part of the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: EvidenceExpand
Incidence of thrombocytopenia in an acute care hospital.
  • C. Teo, Y. Kueh
  • Medicine
  • Annals of the Academy of Medicine, Singapore
  • 1989
TLDR
The high association between thrombocytopenia and infection justifies a search for an infective process when one encounters an unexpected or unexplained reduction in the platelet count. Expand
Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology.
TLDR
The possible consequences of different approaches to the use of platelet transfusion were considered in evaluating a preference for one or another technique producing similar outcomes and cost alone was not a determining factor. Expand
...
1
2
3
4
5
...